完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.author | Chen, KT | en_US |
dc.contributor.author | Lin, JD | en_US |
dc.contributor.author | Liou, MJ | en_US |
dc.contributor.author | Weng, HF | en_US |
dc.contributor.author | Chang, CA | en_US |
dc.contributor.author | Chan, EC | en_US |
dc.date.accessioned | 2014-12-08T15:17:33Z | - |
dc.date.available | 2014-12-08T15:17:33Z | - |
dc.date.issued | 2006-01-18 | en_US |
dc.identifier.issn | 0304-3835 | en_US |
dc.identifier.uri | http://dx.doi.org/10.1016/j.canlet.2005.01.039 | en_US |
dc.identifier.uri | http://hdl.handle.net/11536/12728 | - |
dc.description.abstract | Platelet-derived growth factor receptor (PDGFR) can bind to its ligand and consequently possess a kinase activity, and which is associated with the carcinogenesis of different cell types, including astrocytomas, oligodendrogliomas. and glioblastoma. In a cDNA microarray analysis, we observe the over-expressed mRNA of both PDGF-A and PDGF-alpha receptor in thyroid carcinoma cells. And the elevated protein expressions of PDGF-A and PDGF-alpha receptor in thyroid carcinoma cells were also confirmed by a Western blot analysis. The phosphorylation of PDGF-alpha receptor evaluated by an antibody against Tyr 720-phosphate was found in thyroid carcinoma cells. The tyrosine kinase activity of PDGF-alpha receptor was inhibited by tyrphostin AG1295 and showed a dose-dependent inhibition for the proliferation of thyroid carcinoma cells. These findings imply that autocrine activation of PDGF-alpha receptor plays a crucial role in the carcinogenesis of thyroid cells. (c) 2005 Elsevier Ireland Ltd. All rights reserved. | en_US |
dc.language.iso | en_US | en_US |
dc.subject | platelet-derived growth factor-A | en_US |
dc.subject | platelet-derived growth factor alpha-receptor | en_US |
dc.subject | autocrine activation | en_US |
dc.subject | thyroid carcinoma cell line | en_US |
dc.title | An aberrant autocrine activation of the platelet-derived growth factor alpha-receptor in follicular and papillary thyroid carcinoma cell lines | en_US |
dc.type | Article | en_US |
dc.identifier.doi | 10.1016/j.canlet.2005.01.039 | en_US |
dc.identifier.journal | CANCER LETTERS | en_US |
dc.citation.volume | 231 | en_US |
dc.citation.issue | 2 | en_US |
dc.citation.spage | 192 | en_US |
dc.citation.epage | 205 | en_US |
dc.contributor.department | 生物科技學系 | zh_TW |
dc.contributor.department | Department of Biological Science and Technology | en_US |
dc.identifier.wosnumber | WOS:000234955900006 | - |
dc.citation.woscount | 9 | - |
顯示於類別: | 期刊論文 |